Notícias e Atividades da Opko Health

Opko Health é uma das ...

• Russell 3000;
• TOB Iconic 10,000.

Opko Health é uma empresa listada sob o símbolo OPK (US).

Opko Health possui 3 subsidiárias incluindo Bio-Reference Laboratories, ModeX Therapeutics e Opko Renal.

Eles estão dentro:

• Saúde50%
• Farmacêutica25%
• Outro25%

Veja o organograma con seus 41 executivos principais

Biografias mais buscadas da Opko Health

• Phillip Frost, Chairman of the Board & Chief Executive Officer
• Prem Lachman, Director
• Alice Lin-Tsing Yu, Director

Criar um alerta
para seguir os movimentos de executivos da Opko Health.

Opko Health possui 1.837 concorrentes concorrentes Pfizer (Estados Unidos), Johnson & Johnson (Estados Unidos) e Sanofi (França).

Popular M&A news in Farmacêutica

• Supernus Pharmaceuticals has announced the acquisition of Sage Therapeutics  (publicado em 16 de junho de 2025).
• Juvenescence acaba de anunciar uma arrecadação de fundos de 76 milhões de dólares. (publicado em 22 de maio de 2025).
• Kincell Bio acaba de anunciar uma arrecadação de fundos de 22 milhões de dólares. (publicado em 22 de maio de 2025).

Outros contatos sugeridos na indústria do Farmacêutica

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets da Bristol-Myers Squibb
• Amanda Moore - Vice President, Program Leadership and Clinical Operations da Abeona Therapeutics
• Jean-Michel Demeure - Vice President, Finance Global Operations da Sanofi

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de Opko Health

• OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
• OPKO Health to Participate in Two Upcoming Investor Conferences
• OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
• OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
• OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
• Press Releases
• OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
• OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck
• OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
• View more press releases Close

Redes sociais sobre Opko Health

• Opko Health na Wikipedia, Google News e Yahoo Finance
• Opko Health na LinkedIn, Twitter e YouTube